BioNano Genomics Inc. stock price down 1.44% on Tuesday
(Updated on September 28, 2021)
Sell candidate since 2021-09-24 Loss -0.55% PDF
The BioNano Genomics Inc. stock price fell by -1.44% on the last day (Tuesday, 28th Sep 2021) from $5.54 to $5.46. During the day the stock fluctuated 3.37% from a day low at $5.34 to a day high of $5.52. The price has risen in 7 of the last 10 days and is up by 5% over the past 2 weeks. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 9 million shares were bought and sold for approximately $48.56 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.99% during the next 3 months and, with a 90% probability hold a price between $3.81 and $5.20 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Signals & Forecast
There are mixed signals in the stock today. The BioNano Genomics Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $5.59. On a fall, the stock will find some support from the short-term average at $5.42. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. A buy signal was issued from a pivot bottom point on Thursday, August 19, 2021, and so far it has risen 6.23%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss
BioNano Genomics Inc. finds support from accumulated volume at $5.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.18 between high and low, or 3.37%. For the last week, the stock has had a daily average volatility of 4.27%.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is BioNano Genomics Inc. stock A Buy?
BioNano Genomics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.046
Predicted Opening Price for BioNano Genomics Inc. of Wednesday, September 29, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price September 29, 2021||Current price|
Remember To Visit Our YouTube Channel
On June 16, 2021 "BTIG Research" gave "$10.00" rating for BNGO. The price target was set to $6.75+2.8%.
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.